Trial Profile
Cardiac effects of Ceralifimod
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 30 Nov 2017
Price :
$35
*
At a glance
- Drugs Ceralifimod (Primary) ; Fingolimod
- Indications Multiple sclerosis
- Focus Adverse reactions; Pharmacodynamics
- 19 Feb 2015 New trial record